Adma Biologics Inc Earnings

Adma Biologics Inc’s revenue jumped 40.22% since last year same period to $114.8Mn in the Q1 2025. On a quarterly growth basis, Adma Biologics Inc has generated -2.34% fall in its revenue since last 3-months.

Adma Biologics Inc’s net profit jumped 51.1% since last year same period to $26.9Mn in the Q1 2025. On a quarterly growth basis, Adma Biologics Inc has generated -75.96% fall in its net profits since last 3-months.

Adma Biologics Inc’s net profit margin jumped 7.76% since last year same period to 23.44% in the Q1 2025. On a quarterly growth basis, Adma Biologics Inc has generated -75.38% fall in its net profit margins since last 3-months.

Adma Biologics Inc’s price-to-earnings ratio after this Q1 2025 earnings stands at 21.58.

Adma Biologics Inc’s earning per share (EPS) estimates for the current quarter stand at 0.17 - a 13.63% jump from last quarter’s estimates.

Adma Biologics Inc’s earning per share (EPS) estimates for the current year stand at 0.17.

Adma Biologics Inc’s earning per share (EPS) fell -100% since last year same period to 0 in the Q2 2025. This indicates that the Adma Biologics Inc has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.